GlaxoSmithKline
GSK
$41.24
Share price
1.60%
Change (1 day)
12.52%
Change (1 year)
Categories
Operating Margin for GlaxoSmithKline (GSK)
Operating Margin as of April 2024 (TTM): 22.54%
According to GlaxoSmithKline's latest financial reports and stock price the company's current Operating Margin is 22.54%. At the end of 2022 the company had an Operating Margin of 22.19%.
Operating Margin history for GlaxoSmithKline from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 22.19% | 21.59% |
| 2021 | 18.25% | -20.82% |
| 2020 | 23.05% | 9.08% |
| 2019 | 21.13% | 16.35% |
| 2018 | 18.16% | 28.73% |
| 2017 | 14.11% | 47.1% |
| 2016 | 9.59% | -79.66% |
| 2015 | 47.16% | 193.65% |
| 2014 | 16.06% | -42.58% |
| 2013 | 27.97% | -1.42% |
| 2012 | 28.38% | -8.54% |
| 2011 | 31.03% | 120.88% |
| 2010 | 14.05% | -54.06% |
| 2009 | 30.58% | 4.27% |
| 2008 | 29.32% | -15.73% |
| 2007 | 34.80% | -0.84% |
| 2006 | 35.10% | 5.83% |
| 2005 | 33.16% | 7.93% |
| 2004 | 30.73% | 1.76% |
| 2003 | 30.19% | 13.42% |
| 2002 | 26.62% | -10.43% |
| 2001 | 29.72% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -23.38% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 53.55% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -19.21% | 🇫🇷 France |
 Merck MRK | 27.73% | 23.03% | 🇺🇸 USA |
 AstraZeneca AZN | 5.63% | -75.02% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -20.53% | -191.08% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | 17.64% | -21.74% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.